Moreover, genetic knockdown of PRDM1 attenuated RIS-driven chemoresistance whereas PRDM1 overexpression improved cancer cell survival (Fig. 5b), indicating that cellular ribosomal stress mitigates conventional chemotherapeutic actions via PRDM1 protein. This evidence concerns the gene PRDM1 and cancer.